![Gregory Demopulos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gregory Demopulos
Vorstandsvorsitzender bei
OMEROS CORPORATION
Vermögen: 16 Mio $ am 31.05.2026
Profil
Gregory A. Demopulos is the founder of Omeros Corp., founded in 1994, holding the titles of Chairman, President & Chief Executive Officer since 2013.
Current jobs include Director at Onconome, Inc., Director at Tessera, Inc., Director at Northwest NeuroNeighborhood, and Trustee at Smead Funds Trust.
Education history includes undergraduate studies at Stanford University and a doctorate from Stanford University School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
OMEROS CORPORATION 2,03 % | 17.04.2026 | 1 469 308 ( 2,03 % ) | 16 Mio $ | 31.05.2026 |
Aktive Positionen von Gregory Demopulos
| Unternehmen | Position | Beginn |
|---|---|---|
| OMEROS CORPORATION | Vorstandsvorsitzender | 16.06.1994 |
Tessera, Inc.
 Tessera, Inc. SemiconductorsElectronic Technology Provides packaging solutions for the semiconductor industry | Direktor/Vorstandsmitglied | - |
Onconome, Inc.
 Onconome, Inc. Medical SpecialtiesHealth Technology Provides development and commercialization of innovative biomarkers | Direktor/Vorstandsmitglied | - |
Smead Funds Trust
 Smead Funds Trust Investment Trusts/Mutual FundsMiscellaneous Acts as Open-End Investment Fund/Unit Trust | Direktor/Vorstandsmitglied | - |
Northwest NeuroNeighborhood | Direktor/Vorstandsmitglied | - |
Ausbildung von Gregory Demopulos
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
40
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Omeros Corp.
 Omeros Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes small-molecule & protein therapeutics | Health Technology |
Onconome, Inc.
Onconome, Inc. Medical SpecialtiesHealth Technology Provides development and commercialization of innovative biomarkers | Health Technology |
Smead Funds Trust
Smead Funds Trust Investment Trusts/Mutual FundsMiscellaneous Acts as Open-End Investment Fund/Unit Trust | Miscellaneous |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tessera, Inc.
Tessera, Inc. SemiconductorsElectronic Technology Provides packaging solutions for the semiconductor industry | Electronic Technology |
Stanford University School of Medicine
 Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northwest NeuroNeighborhood |
